Evidence-based supplement stacks designed to support your peptide protocols — what to take alongside, when, and why.
The biochemical cofactors your body needs to support DSIP (Delta Sleep-Inducing Peptide) therapy.
Evidence-based supplement companion for DSIP (Delta Sleep-Inducing Peptide): dSIP was named for inducing delta sleep, but independent labs failed to replicate that in humans, no one has found its receptor or gene, and its best human stress trial found zero effect. Fascinating biology, unproven clinically.
The biochemical cofactors your body needs to support Cerebrolysin therapy.
Evidence-based supplement companion for Cerebrolysin: cerebrolysin is a porcine-brain peptide mixture sold as a master key for brain repair. It has decades of human trials, approval in 50+ countries, no FDA approval, and a Cochrane safety signal that complicates the story.
The biochemical cofactors your body needs to support KPV (Lysine-Proline-Valine) therapy.
Evidence-based supplement companion for KPV (Lysine-Proline-Valine): kPV is the three-amino-acid tail of alpha-MSH: it keeps the parent hormone's anti-inflammatory power, drops the pigmentation, and targets inflamed tissue through the PepT1 transporter. The catch: every result so far is from cells or animals.
The biochemical cofactors your body needs to support AOD-9604 (hGH Fragment 176-191) therapy.
Evidence-based supplement companion for AOD-9604 (hGH Fragment 176-191): a 16-amino-acid fragment of human growth hormone engineered to trigger fat metabolism without activating the GH receptor, AOD-9604 cleared early clinical trials for obesity before its key Phase IIb collapsed under a placebo response. Now stripped of FDA Category 2 status and banned by WADA, its most interesting data may be in a direction nobody expected: cartilage repair.
The biochemical cofactors your body needs to support MK-677 (Ibutamoren) therapy.
Evidence-based supplement companion for MK-677 (Ibutamoren): the oral compound that reliably raises GH and IGF-1 to youthful levels, delivers measurable gains in lean mass and sleep architecture, yet consistently failed to translate those biomarker wins into functional outcomes across 30 years of clinical trials.
The biochemical cofactors your body needs to support PT-141 (Bremelanotide) therapy.
Evidence-based supplement companion for PT-141 (Bremelanotide), the first FDA-approved peptide that targets the brain's desire circuitry instead of the body's vascular hardware, opening a new front in sexual medicine, appetite regulation, and central neuromodulation.
The biochemical cofactors your body needs to support Tirzepatide therapy.
Evidence-based supplement companion for Tirzepatide: the first dual-action incretin that outpaces single-agonist therapy across weight, glucose, heart failure, and sleep apnoea, while forcing medicine to reckon with the musculoskeletal cost of rapid metabolic transformation.
The biochemical cofactors your body needs to support Semaglutide therapy.
Evidence-based supplement companion for Semaglutide: the GLP-1 receptor agonist reshaping metabolic medicine, from weight loss to cardiovascular protection, liver repair, and beyond.
The biochemical cofactors your body needs to support ARA-290 therapy.
Evidence-based supplement companion for ARA-290: an 11-amino-acid peptide derived from erythropoietin's helix-B surface that selectively activates the Innate Repair Receptor, triggering nerve regeneration and tissue protection without the blood-thickening risks of EPO.